Skip to content

US National OCS Heart Perfusion (OHP) Registry

US National OCS Heart Perfusion (OHP) Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05915299
Enrollment
100000
Registered
2023-06-22
Start date
2023-08-25
Completion date
2033-08-31
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Transplant

Brief summary

This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.

Detailed description

The objective of this US National OHP Registry is to collect data on the post-transplant clinical outcomes of all donor hearts preserved and assessed on the OCS Heart System and to document the performance of the OCS Heart device in the real-world setting after FDA approval in the US. The US National OHP Registry will enroll all heart transplant recipients who are transplanted with an OCS-perfused donor heart in the Registry. Patients' clinical outcomes will be followed up to five years post-transplant, loss to follow up, or death, whichever occurs first.

Interventions

DEVICEOCS Heart

The TransMedics® Organ Care System (OCS) Heart System is an FDA approved portable extracorporeal heart perfusion and monitoring system. The OCS Heart System's innovative technology was designed to comprehensively overcome the historical limitations of cold storage. The OCS Heart System expands the utilization of donor hearts by enabling the use of donor hearts deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of cold static cardioplegic preservation.

Sponsors

TransMedics
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* N/A

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Recipients' patient and graft survivalUp to 5 years post-transplantRecipients' patient and graft survival rates will be the primary clinical outcomes measures for all OCS Heart transplanted recipients compared to recipients receiving heart transplants using non-OCS preservation methods (cold static storage or other perfusion devices or a combination of both). This data will be obtained directly from UNOS/OPTN database.

Countries

United States

Contacts

Primary ContactRaicca Haqqi
rhaqqi@transmedics.com9788090620
Backup ContactKausar Qidwai
kqidwai@transmedics.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026